| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. (VIR) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. VIR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.73M | $139.49M | - | |
| Dir | 1.10M | $11.18M | - | |
| CEO | 714.6K | $7.26M | - | |
| CFO | 160.1K | $1.63M | - | |
| VP | 104.6K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 7,900 | $63.74 | $503,576.81 | -9.6% | |
| Feb 9, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 7,900 | $71.16 | $562,160.84 | -19.2% | |
| Feb 1, 2021 | Parrish Jay | Chief Business Officer | Sale+OE | 6,944 | $69.91 | $485,424.49 | -3.0% | |
| Jan 26, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 31,300 | $48.17 | $1,507,805.51 | -48.5% | |
| Jan 15, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 10,530 | $38.00 | $400,140.00 | -24.1% | |
| Jan 12, 2021 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,805 | $29.36 | $111,696.16 | -10.3% | |
| Jan 4, 2021 | Parrish Jay | Chief Business Officer | Sale+OE | 6,945 | $26.32 | $182,795.18 | -3.0% | |
| Dec 22, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,805 | $31.19 | $118,682.52 | -13.8% | |
| Dec 8, 2020 | Virgin Herbert83 | EVP, Research &CSO | Sale+OE | 3,805 | $31.27 | $118,965.61 | -13.8% | |
| Dec 1, 2020 | Parrish Jay | Chief Business Officer | Sale+OE | 6,945 | $31.53 | $218,967.52 | -3.0% |